Targeted interventions, including simplification of the insulin regimen from CSII to MDI and zinc repletion, proved effective in stabilizing glycemic control and restoring patient confidence, although one further hospitalization occurred due to post-COVID-19 anorexia without DKA. This evidence concerns the gene INS and COVID-19.